Avid Bioservices IncNASDAQ:CDMO
- LAST PRICE12.2450
- TODAY'S CHANGE (%)-0.0050 (-0.0408%)
- Bid / Lots12.2400/ 837
- Ask / Lots12.2500/ 334
- Open / Previous Close12.2500 / 12.2500
- Day Range
- 52 Week Range
- Volume663,916
Search Criteria
Filter search criteria using below inputs
Click on magnifying glass icon to search
| Company | Country | Symbol |
|---|
- TSX Comp
- TSX Venture
- DJIA
- S&P 500
- NASDAQ
| Time | Volume | CDMO |
|---|---|---|
| 09:32 ET | 85206 | 12.26 |
| 09:33 ET | 46244 | 12.26 |
| 09:35 ET | 58203 | 12.25 |
| 09:37 ET | 7677 | 12.25 |
| 09:39 ET | 8611 | 12.25 |
| 09:42 ET | 66084 | 12.25 |
| 09:44 ET | 13414 | 12.25 |
| 09:46 ET | 6598 | 12.25 |
| 09:48 ET | 33514 | 12.25 |
| 09:50 ET | 16608 | 12.25 |
| 09:51 ET | 13801 | 12.25 |
| 09:53 ET | 1361 | 12.25 |
| 09:55 ET | 10667 | 12.25 |
| 09:57 ET | 1414 | 12.25 |
| 10:00 ET | 2000 | 12.255 |
| 10:02 ET | 4100 | 12.25 |
| 10:04 ET | 1300 | 12.25 |
| 10:06 ET | 1200 | 12.255 |
| 10:08 ET | 18565 | 12.25 |
| 10:09 ET | 33389 | 12.25 |
| 10:11 ET | 74462 | 12.245 |
| 10:13 ET | 69796 | 12.245 |
| 10:15 ET | 44603 | 12.245 |
Today
Yesterday
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, ALVR, VINE, ROIC on Behalf of Shareholders, from 22 hours ago by Dow Jones
22 hours ago by Dow Jones$hareholder Alert: The M&A Class Action Firm Launches Legal Inquiry the Merger ROIC, VINE, ALVR and CDMO, from 23 hours ago by Dow Jones
23 hours ago by Dow Jones
Nov 10, 2024
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates CDMO, ALVR, VINE on Behalf of Shareholders, from 5:04PM ET on Sunday Nov 10, 2024 by Dow Jones
5:04PM ET on Sunday Nov 10, 2024 by Dow Jones$hareholder Alert: The M&A Class Action Launches Legal Inquiry for the Merger of ROIC, VINE, ALVR and CDMO, from 2:31PM ET on Sunday Nov 10, 2024 by Dow Jones
2:31PM ET on Sunday Nov 10, 2024 by Dow Jones
| Company sortable | Market Cap sortable | P/E Ratio (TTM) sortable | EPS Growth (5yr) sortable |
|---|---|---|---|
Avid Bioservices Inc | 781.5M | -5.4x | --- |
Entrada Therapeutics Inc | 744.3M | 12.4x | --- |
Adaptive Biotechnologies Corp | 957.1M | -4.4x | --- |
Arcturus Therapeutics Holdings Inc | 550.9M | -8.3x | --- |
Sangamo Therapeutics Inc | 562.2M | -2.0x | --- |
Kamada Ltd | 350.7M | 20.6x | -22.48% |
Company Information
Avid Bioservices, Inc. is a dedicated contract development and manufacturing organization (CDMO) focused on development and Current Good Manufacturing Practices (CGMP) manufacturing of biologics. The Company provides a comprehensive range of process development, CGMP clinical and commercial manufacturing services for the biotechnology and biopharmaceutical industries. Its services include CGMP clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. For early-stage programs the Company provides a variety of process development activities, including cell line development, upstream and downstream development and optimization, analytical methods development, testing and characterization. The scope of its services ranges from standalone process development projects to full development and manufacturing programs through commercialization. Commercial biologics produced by it are distributed to over 90 countries.
Contact Information
- Headquarters
- 14191 MYFORD ROADTUSTIN, CA, United States 92780
- Phone
- 714-508-6100
- Fax
- 714-838-5817
Executives
- Independent Chairman of the Board
- Joseph Carleone
- President, Chief Executive Officer, Director
- Nicholas Green
- Chief Financial Officer
- Daniel Hart
- Chief Operations Officer
- Richard Richieri
- Vice President, General Counsel, Corporate Secretary
- Mark Ziebell
Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.
Open a New Account, or Login if you're a client.
You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.
Open a New Account, or Login if you're a client.
Market Cap | $781.5M |
|---|---|
Revenue (TTM) | $142.4M |
Shares Outstanding | 63.8M |
Dividend Yield | 0.00% |
Annual Dividend Rate | --- |
Ex-Dividend Date | 01-01-01 |
Pay Date | 01-01-01 |
Beta | 1.44 |
EPS | $-2.27 |
Book Value | $0.96 |
P/E Ratio | -5.4x |
Price/Sales (TTM) | 5.5 |
Price/Cash Flow (TTM) | --- |
Operating Margin | -14.66% |
Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.
Open a New Account, or Login if you're a client.
